Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials Strategic collaboration marks the first time patients using LillyDirect, Lilly's direct-to-consumer healthcare platform, can access self-pay pricing for Zepbound vials at a retail pharmacy location LillyDirect pick-up option at Walmart offers millions of Americans living with obesity additional convenience, access and choice in how they get their medication INDIANAPOLIS , Oct. 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Walmart Inc. (NYSE: WMT) today announced a collaboration to expand access to direct-to-consumer pricing for Zepbound (tirzepatide) single-dose vials …

NORTHBROOK, Ill. , Oct. 29, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported: The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.6%, on the quarterly cash dividend on the Company's common stock.

Net income for the third quarter of 2025 of $1,216 million, or $6.98 per share. Record adjusted net income for the third quarter of 2025 of $865 million, or $4.97 per share.

MONTRÉAL, Oct. 29, 2025 /PRNewswire/ - BCE (TSX: BCE) (NYSE: BCE) announced today that Gordon Nixon, who will reach the end of his 12-year term in 2026, will step down as Chair and not seek re-election as a Director at the Annual General Shareholder Meeting on May 7, 2026. Mr. Nixon joined the Board in 2014 and served as Chair for 10 years.

Blackbaud launches new AI innovation at annual bbcon conference CHARLESTON, S.C. , Oct. 29, 2025 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today announced financial results for its third quarter ended September 30, 2025.

Raises Full Year 2025 Margin Outlook Announces Intention to Redomicile to Luxembourg and List Ordinary Shares on Nasdaq Names Amazon Veteran Edouard Dinichert as Chief Customer Officer NEW YORK , Oct. 29, 2025 /PRNewswire/ -- Criteo S.A. (NASDAQ: CRTO) ("Criteo" or the "Company"), the global platform connecting the commerce ecosystem, today announced financial results for the third quarter ended September 30, 2025.

Leading global private markets firm Hamilton Lane launches private markets indices on Bloomberg, providing investors robust benchmarking for private equity, credit, and real assets fund performance NEW YORK and CONSHOHOCKEN, Pa. , Oct. 29, 2025 /PRNewswire/ -- Bloomberg today announced the addition of Hamilton Lane's (Nasdaq: HLNE) suite of twenty private market closed-end fund performance indices to the Bloomberg Terminal and Data License, providing investors with new data and analytical tools to evaluate and compare performance.

In conjunction Company provides guidance on Fiscal 2025 billings and corporate update +394% increase in annualized billings from the Canadian Government Defence business over actual Fiscal 2024 billings. Ottawa, Ontario--(Newsfile Corp. - October 29, 2025) - DEFSEC Technologies Inc. (TSXV: DFSC) (TSXV: DFSC.WT.U) (NASDAQ: DFSC) (NASDAQ: DFSCW) ("DEFSEC" or the "Company") is pleased to announce that it will be attending and presenting at The ThinkEquity Conference in New York City on Thursday October 30, 2025.

Chicago, Illinois--(Newsfile Corp. - October 29, 2025) - Groupon, Inc. (NASDAQ: GRPN) announced today that it intends to release the company's third quarter financial results after the market closes on Thursday, November 6, 2025. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Friday, November 7, 2025.

ROSELAND, N.J. , Oct. 29, 2025 /PRNewswire/ -- ADP (Nasdaq: ADP), a global leader in HR and payroll solutions, today announced its first quarter fiscal 2026 financial results along with its revised fiscal 2026 outlook through an earnings release available on the company's website at investors.adp.com/events-and-presentations.

ZURICH , Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS" or the "Company"), a biopharmaceutical company focused on developing innovative therapies for central nervous system and neurodegenerative disorders, and Kadimastem Ltd.

CHICAGO , Oct. 29, 2025 /PRNewswire/ -- Donnelley Financial Solutions, Inc. (NYSE: DFIN) (the "Company" or "DFIN") today reported financial results for the third quarter of 2025. Highlights for the third quarter of 2025: Third-quarter software solutions net sales of $90.7 million, an increase of 10.3% from the third quarter of 2024; Software solutions net sales accounted for 51.7% of total net sales, up from 45.8% in the third quarter of 2024.

Net income increased 136.9% year over year to $75.9 million, a Company record for any quarter Adjusted net income1 increased 41.4% year over year to $40.7 million, a Company record for any quarter Total revenue increased 13.5% year over year to $155.1 million, a Company record for any quarter Raised full year revenue guidance to between $590 million and $605 million, adjusted net income1 to between $137 million and $142 million, and adjusted EPS to between $1.54 and $1.60 CHICAGO , Oct. 29, 2025 /PRNewswire/ -- OppFi Inc. (NYSE: OPFI) ("OppFi" or the "Company"), a tech-enabled digital finance platform that …

TULSA, Okla. , Oct. 29, 2025 /PRNewswire/ -- AAON, Inc. (NASDAQ: AAON) ("AAON" or the "Company"), a leader in high-performing, energy-efficient HVAC solutions that brings long-term value to customers and owners, announces that it has scheduled its quarterly conference call and webcast for Thursday, November 6, 2025, at 9:00 a.m.

Company reports record third quarter revenue and operating income, and raises full year EPS guidance SCHAFFHAUSEN, Switzerland , Oct. 29, 2025 /PRNewswire/ -- Garmin® Ltd. (NYSE: GRMN), today announced results for the third quarter ended September 27, 2025.

BROOKLYN, N.Y. , Oct. 29, 2025 /PRNewswire/ -- Etsy, Inc. (NYSE: ETSY), which operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world, today announced results for its third quarter ended September 30, 2025.

The tech giant owes much of its $4.89 trillion market capitalization to the use of its systems to train AI models. Now it's pushing deeper into the realm of corporations that will employ such models to solve real-life problems.

WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that the Company has completed enrollment in its Phase 2 LOTUS trial of AVTX-009 in adults with hidradenitis suppurativa (HS). The LOTUS trial exceeded target enrollment of 222 patients with approximately 250 patients enrolled. Topline data from the trial is expected in mid-2026.

Liquid formulation has potential to expand patient access, including those in intensive care, to SER-155 for the prevention of bloodstream and antimicrobial resistant (AMR) infections Liquid formulation has potential to expand patient access, including those in intensive care, to SER-155 for the prevention of bloodstream and antimicrobial resistant (AMR) infections

Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product